Yunpeng Yang

机构：Sun Yat-sen University, University of California San Diego, Center for Excellence in Brain Science and Intelligence Technology, VA San Diego Healthcare System, Yango University, Department of Physics, Mathematics and Informatics, Department of Biological Sciences, Yangzhou Vocational University, Sun Yat-sen University Cancer Center, Shanghai Center for Brain Science and Brain-Inspired Technology, Yangzhou University, South China University of Technology, China National Petroleum Corporation (China) · ORCID：0000-0001-5163-0940

发表论文 372 篇 · 总被引 9997 次 · h-index 49

代表论文

• A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial (2025 · Nature Medicine · 被引 88)
• Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial (2025 · Journal of Hematology & Oncology · 被引 26)
• Discovery of an ene-reductase initiating resveratrol catabolism in gut microbiota and its application in disease treatment (2025 · Cell Reports · 被引 16)
• Murine gut microbial interactions exert antihyperglycemic effects (2025 · The ISME Journal · 被引 8)
• Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial (2025 · Signal Transduction and Targeted Therapy · 被引 7)
• Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial (2024 · Journal of Thoracic Oncology · 被引 7)